Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs

scientific article published on 22 April 2008

Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VETIMM.2008.04.011
P698PubMed publication ID18511133
P5875ResearchGate publication ID5340044

P2093author name stringYufeng Li
Ping Jiang
Jianjun Dai
Jing Qi
Yijun Du
Congzhi Li
Shuyi Duan
P2860cites workFoot-and-mouth disease virus: biology and prospects for disease controlQ34935334
Molecular basis of pathogenesis of FMDV.Q35044850
FMD vaccinesQ35044859
New approaches to vaccination against foot-and-mouth diseaseQ35237121
Developments in foot-and-mouth disease vaccinesQ36395476
Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteinsQ37742938
Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth diseaseQ39699303
Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99.Q40433851
Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.Q40452590
An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swineQ40533709
Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.Q40616705
Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structureQ40857755
Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidateQ40920483
Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in miceQ42800320
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.Q44550766
Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virusQ45415581
Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.Q45419096
Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virusQ45600695
Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virusQ45710581
The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cellsQ45730227
Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.Q45733658
Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope proteinQ45734367
Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virusQ45743836
Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1.Q45750862
Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated miceQ45855274
Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virusQ45860075
Expressions of Bovine IFN-gamma and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens.Q54646040
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequenceQ59068267
Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UKQ59097926
Biochemical characterization of FMDV A10 and A22 subtypes by PAGE and IEFQ73045377
Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine modelQ74334942
Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice modelQ79329188
P433issue3-4
P921main subjectfoot-and-mouth diseaseQ152401
AdenoviridaeQ193447
foot-and-mouth disease virusQ1911079
P304page(s)274-283
P577publication date2008-04-22
P1433published inVeterinary Immunology and ImmunopathologyQ7923704
P1476titleImmune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs
P478volume124

Reverse relations

cites work (P2860)
Q42197160A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds.
Q45357895Co-administration of live attenuated Salmonella enterica serovar Typhimurium expressing swine interleukin-18 and interferon-α provides enhanced Th1-biased protective immunity against inactivated vaccine of pseudorabies virus
Q64982394Effect of IL-2 co-expressed or co-inoculated with immuno-dominant epitopes from VP1 protein of FMD virus on immune responses in BALB/c mice.
Q33761087Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1.
Q45375847Live attenuated Salmonella enterica serovar Typhimurium expressing swine interferon-alpha has antiviral activity and alleviates clinical signs induced by infection with transmissible gastroenteritis virus in piglets
Q42188915Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine
Q54377422Production of Recombinant Porcine Interferon alpha Using PHB–Intein-Mediated Protein Purification Strategy

Search more.